📣 VC round data is live. Check it out!
- Public Comps
- Atinum Investment
Atinum Investment Valuation Multiples
Discover revenue and EBITDA valuation multiples for Atinum Investment and similar public comparables like Maven I&G VCT, SV Investment, Agronomics, Creal and more.
Atinum Investment Overview
About Atinum Investment
Atinum Investment Co Ltd is a venture capital firm. Its main activities are venture support services, investment services and corporate restructuring among other.
Founded
1988
HQ

Employees
59
Website
Sectors
Financials (FY)
EV
$94M
Valuation Multiples
Start free trialAtinum Investment Financials
Atinum Investment reported last fiscal year revenue of $47M and EBITDA of $22M.
In the same fiscal year, Atinum Investment generated $39M in gross profit, $22M in EBITDA, and $17M in net income.
Atinum Investment P&L
In the most recent fiscal year, Atinum Investment reported revenue of $47M and EBITDA of $22M.
Atinum Investment is profitable as of last fiscal year, with gross margin of 82%, EBITDA margin of 47%, and net margin of 36%.
Financial data powered by Morningstar, Inc.
Atinum Investment Stock Performance
Atinum Investment has current market cap of $94M, and enterprise value of $94M.
Atinum Investment's stock price is $2.04.
Atinum Investment has an EPS (earnings per share) of $0.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $94M | $94M | 1.5% | - | - | - | $0.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAtinum Investment Valuation Multiples
Atinum Investment trades at 2.0x EV/Revenue multiple, and 4.2x EV/EBITDA.
Atinum Investment Financial Valuation Multiples
As of May 30, 2026, Atinum Investment has market cap of $94M and EV of $94M.
Atinum Investment has a P/E ratio of 5.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Atinum Investment Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Atinum Investment Margins & Growth Rates
In the most recent fiscal year, Atinum Investment reported gross margin of 82%, EBITDA margin of 47%, and net margin of 36%.
Atinum Investment Margins
Atinum Investment Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Atinum Investment Operational KPIs
Atinum Investment's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Atinum Investment Competitors
Atinum Investment competitors include Maven I&G VCT, SV Investment, Agronomics, Creal, Scherzer, Company K Partners, Software Circle, Rbr Log FII, TMT Investments and Gunosy.
Most Atinum Investment public comparables operate across PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 17.7x | - | - | - | |||
| 7.5x | - | (31.5x) | - | |||
| (6.0x) | - | (2.7x) | - | |||
| 0.3x | 0.3x | 5.8x | - | |||
| 4.4x | 4.1x | 6.6x | - | |||
| 5.4x | - | 11.3x | - | |||
| 3.7x | - | 14.2x | - | |||
| 7.2x | - | 7.2x | - | |||
This data is available for Pro users. Sign up to see all Atinum Investment competitors and their valuation data. Start Free Trial | ||||||
Atinum Investment Investment Activity
Atinum Investment has invested in 113 companies to date.
Latest investment by Atinum Investment was on May 18th 2026. Atinum Investment invested in Byte Lab in their $7M Undisclosed stage round (EV/Revenue multiple of ).
Latest Investments by Atinum Investment
| Description | Byte Lab prioritizes achieving long-term results by concentrating on *how* we grew rather than just growing quickly. | Mustbio is a Seoul-based biotechnology firm developing multi-antibody therapeutics for immuno-oncology. The company engineers bispecific and trispecific antibodies targeting solid tumors and hematologic cancers, leveraging proprietary platforms for enhanced efficacy and safety. Mustbio advances candidates through preclinical stages toward clinical trials in South Korea and the US. Founded in 2021, it collaborates with academic institutions on next-generation CAR-T therapies. | - | Sionic AI is an information technology company offering customized AI platforms for business enterprises. Headquartered in Seoul, South Korea, it enables firms to design, deploy, and manage sector-specific models for sales forecasting, customer service, and operations optimization. | |
| HQ Country | |||||
| HQ City | Seoul | Seoul | - | Seoul | |
| Deal Date | 18 May 2026 | 12 Mar 2026 | 29 Dec 2025 | 1 Dec 2025 | |
| Round | Undisclosed stage | Series C | Undisclosed stage | Series A | |
| Raised | $7M | $24M | $14M | $17M | |
| Investors | Atinum Investment; CJ Olive Young | Anguk Health; Atinum Investment; BNH Investment; Korea Development Bank; Korea Investment Partners; Partners Investment; Premier Partners; Shinhan Capital; WONIK Investment Partners | Atinum Investment; Korea Development Bank | Atinum Investment; BSK Investment; Flux Ventures; IMM Investment; Industrial Bank of Korea; Korea Investment Partners; KT Investment; LB Investment; Mirae Asset Venture Investment; Naver Cloud; Partners Investment; Samsung Venture Investment | |
| Valuation | undisclosed | $65M | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Atinum Investment investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Atinum Investment
| When was Atinum Investment founded? | Atinum Investment was founded in 1988. |
| Where is Atinum Investment headquartered? | Atinum Investment is headquartered in South Korea. |
| How many employees does Atinum Investment have? | As of today, Atinum Investment has over 59 employees. |
| Is Atinum Investment publicly listed? | Yes, Atinum Investment is a public company listed on Korea Exchange. |
| What is the stock symbol of Atinum Investment? | Atinum Investment trades under 021080 ticker. |
| When did Atinum Investment go public? | Atinum Investment went public in 1996. |
| Who are competitors of Atinum Investment? | Atinum Investment main competitors include Maven I&G VCT, SV Investment, Agronomics, Creal, Scherzer, Company K Partners, Software Circle, Rbr Log FII, TMT Investments, Gunosy. |
| What is the current market cap of Atinum Investment? | Atinum Investment's current market cap is $94M. |
| What is the current revenue of Atinum Investment? | Atinum Investment's last fiscal year revenue is $47M. |
| What is the current EV/Revenue multiple of Atinum Investment? | Current revenue multiple of Atinum Investment is 2.0x. |
| Is Atinum Investment profitable? | No, Atinum Investment is not profitable. |
| How many companies Atinum Investment has acquired to date? | Atinum Investment hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Atinum Investment has invested to date? | As of May 2026, Atinum Investment has invested in 113 companies. |
| What was the last Atinum Investment investment? | On 18th May 2026 Atinum Investment invested in Byte Lab, participating in a $7M Undisclosed stage round, alongside CJ Olive Young. |
| In what companies Atinum Investment invested in? | Atinum Investment invested in Klook Technology, Nium, Valo Health, RIDI, Berkeley Lights, Orum Therapeutics, Brandi, MarqVision, Contec, PineTree Therapeutics, Profusa, Nex Eye, Bungaejangter, Cupix, Pace, Banksalad, Rainist, Curocell, Standigm, Law&Company, and 93 other companies. |
See public comps similar to Atinum Investment
Lists including Atinum Investment
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
